<?xml version="1.0" encoding="utf-8"?>
	<!-- generator="Podcast Generator 1.0beta4a" -->
		<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xml:lang="en" version="2.0">
	<channel>
		<title>Gastroenterology</title>
		<link>http://digitalstash.net/podcasts/AGA/GASTRO//</link>
		<description>An engaging, informative mix of author interviews and expert commentary on the latest articles from Gastroenterology, hosted by the journal's Online Editor, John F. Kuemmerle, MD, AGAF. 
</description>
		<generator>Podcast Generator 1.0beta4a - http://podcastgen.sourceforge.net</generator>
	<lastBuildDate>Mon, 01 Feb 2010 10:46:31 -0500</lastBuildDate>
		<language>en</language>
		<copyright>AGA Institute</copyright>
		<itunes:image href="http://digitalstash.net/podcasts/AGA/GASTRO//images/itunes_image.jpg" />
		<image>
		<url>http://digitalstash.net/podcasts/AGA/GASTRO//images/itunes_image.jpg</url>
		<title>Gastroenterology</title>
		<link>http://digitalstash.net/podcasts/AGA/GASTRO//</link>
		</image>
		<itunes:summary>An engaging, informative mix of author interviews and expert commentary on the latest articles from Gastroenterology, hosted by the journal's Online Editor, John F. Kuemmerle, MD, AGAF. 
</itunes:summary>
		<itunes:subtitle>An engaging, informative mix of author interviews and expert commentary on the latest articles from Gastroenterology, hosted by the journal's Online Editor, John F. Kuemmerle, MD, AGAF. 
</itunes:subtitle>
		<itunes:author>AGA Institute</itunes:author>
		<itunes:owner>
		<itunes:name>AGA Institute</itunes:name>
		<itunes:email>gastropodcast@gastro.org</itunes:email>
		</itunes:owner>
		<itunes:explicit>clean</itunes:explicit>
		<itunes:category text="Science &amp; Medicine">
			</itunes:category>
			<item>
								<title>Colorectal Neoplasia in Inflammatory Bowel Disease</title>
								<itunes:subtitle>An AGA medical position statement and technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease appear in the February 2010 issue of Gastroenterology.  Dr. Kuemmerle speaks with author Dr. Francis A. Farraye.</itunes:subtitle>
								<itunes:summary><![CDATA[ An AGA medical position statement and technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease appear in the February 2010 issue of &lt;i&gt;Gastroenterology&lt;/i&gt;.  Dr. Kuemmerle speaks with one of the authors, Dr. Francis A. Farraye of Boston University School of Medicine. ]]></itunes:summary>
								<description>An AGA medical position statement and technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease appear in the February 2010 issue of Gastroenterology.  Dr. Kuemmerle speaks with author Dr. Francis A. Farraye.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2010-02-01_gastroenterology_podcast_february_2010.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2010-02-01_gastroenterology_podcast_february_2010.mp3" length="9950914" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2010-02-01_gastroenterology_podcast_february_2010.mp3</guid>
								<itunes:duration>13:48</itunes:duration>
									<author>gastropodcast@gastro.org (AGA)</author>
									<itunes:author>gastropodcast@gastro.org</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 01 Feb 2010 10:43:37 -0500</pubDate>
								</item><item>
								<title>Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres</title>
								<itunes:subtitle>A study in the January 2010 Gastroenterology assesses long-term clinical outcomes of Hepatocellular carcinoma patients treated with intra-arterial yttrium-90 microspheres.  Dr. Kuemmerle speaks to senior author Dr. Riad Salem.</itunes:subtitle>
								<itunes:summary><![CDATA[ A study in the January 2010 &lt;i&gt;Gastroenterology&lt;/i&gt; assesses long-term clinical outcomes of Hepatocellular carcinoma patients treated with intra-arterial yttrium-90 microspheres.  Dr. Kuemmerle speaks to senior author Dr. Riad Salem from the Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois.   ]]></itunes:summary>
								<description>A study in the January 2010 Gastroenterology assesses long-term clinical outcomes of Hepatocellular carcinoma patients treated with intra-arterial yttrium-90 microspheres.  Dr. Kuemmerle speaks to senior author Dr. Riad Salem.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-12-30_gastroenterology_podcast_january_2010.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-12-30_gastroenterology_podcast_january_2010.mp3" length="8449721" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-12-30_gastroenterology_podcast_january_2010.mp3</guid>
								<itunes:duration>11:43</itunes:duration>
									<author>gastropodcast@gastro.org (AGA)</author>
									<itunes:author>gastropodcast@gastro.org</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Wed, 30 Dec 2009 14:28:09 -0500</pubDate>
								</item><item>
								<title>Predicted Response of Chronic HBV Patients to Therapy with Peginterferon-Alfa</title>
								<itunes:subtitle>A study in the December 2009 Gastroenterology looks at factors that predict response of patients with chronic hepatitis B virus (HBV) infection to therapy with pegylated interferon (PEG-IFN)–alfa.</itunes:subtitle>
								<itunes:summary><![CDATA[ A study in the December 2009 Gastroenterology looks at factors that predict response of patients with chronic hepatitis B virus (HBV) infection to therapy with pegylated interferon (PEG-IFN)–alfa.  Dr. Kuemmerle speaks to study author Dr. Harry Janssen of the Department of Gastroenterology and Hepatology at the University Medical Center Rotterdam.   ]]></itunes:summary>
								<description>A study in the December 2009 Gastroenterology looks at factors that predict response of patients with chronic hepatitis B virus (HBV) infection to therapy with pegylated interferon (PEG-IFN)–alfa.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-11-30_gastroenterology_podcast_december_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-11-30_gastroenterology_podcast_december_2009.mp3" length="9699860" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-11-30_gastroenterology_podcast_december_2009.mp3</guid>
								<itunes:duration>13:27</itunes:duration>
									<author>gastropodcast@gastro.org (AGA)</author>
									<itunes:author>gastropodcast@gastro.org</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 30 Nov 2009 16:26:54 -0500</pubDate>
								</item><item>
								<title>Gastroesophageal Reflux Might Cause Esophagitis Through a Cytokine-Mediated Mechanism Rather Than Caustic Acid Injury</title>
								<itunes:subtitle>A study in the November 2009 Gastroenterology looks at a possible alternative concept for the development of reflux esophagitis.</itunes:subtitle>
								<itunes:summary><![CDATA[ A study in the November 2009 Gastroenterology looks at a possible alternative concept for the development of reflux esophagitis.  Dr. Kuemmerle hosts a discussion with authors Dr. Rhonda F. Souza and Dr. Stuart J. Spechler, both of the VA North Texas Health Care System and the University of Texas Southwestern Medical School. ]]></itunes:summary>
								<description>A study in the November 2009 Gastroenterology looks at a possible alternative concept for the development of reflux esophagitis.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-10-26_gastroenterology_podcast_november_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-10-26_gastroenterology_podcast_november_2009.mp3" length="10037727" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-10-26_gastroenterology_podcast_november_2009.mp3</guid>
								<itunes:duration>13:55</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 26 Oct 2009 10:45:30 -0400</pubDate>
								</item><item>
								<title>Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab</title>
								<itunes:subtitle>A study in the October 2009 Gastroenterology compares  colectomy rates following treatment of ulcerative colitis with placebo or infliximab</itunes:subtitle>
								<itunes:summary><![CDATA[ A study in the October 2009 Gastroenterology compares  colectomy rates following treatment of ulcerative colitis with placebo or infliximab.  Dr. Kuemmerle speaks with the senior author, Dr. William Sandborn of the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. ]]></itunes:summary>
								<description>A study in the October 2009 Gastroenterology compares  colectomy rates following treatment of ulcerative colitis with placebo or infliximab</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-09-29_gastroenterology_podcast_october_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-09-29_gastroenterology_podcast_october_2009.mp3" length="10370675" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-09-29_gastroenterology_podcast_october_2009.mp3</guid>
								<itunes:duration>14:23</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Tue, 29 Sep 2009 12:17:08 -0400</pubDate>
								</item><item>
								<title>Coinfection With HIV-1 and HCV — A One-Two Punch</title>
								<itunes:subtitle>Dr. Arthur Kim of Massachusetts General Hospital discusses HIV-1 and HCV coinfection.</itunes:subtitle>
								<itunes:summary><![CDATA[ Dr. Arthur Kim of Massachusetts General Hospital discusses HIV-1 and HCV coinfection. This review article in the September 2009 issue of Gastroenterology examines how these viruses interact with the host immune system, with a dual focus on pathways to viral persistence and mechanisms that might underlie accelerated liver disease. ]]></itunes:summary>
								<description>Dr. Arthur Kim of Massachusetts General Hospital discusses HIV-1 and HCV coinfection.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-08-31_gastroenterology_podcast_september_2009_1.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-08-31_gastroenterology_podcast_september_2009_1.mp3" length="9684770" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-08-31_gastroenterology_podcast_september_2009_1.mp3</guid>
								<itunes:duration>13:26</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 31 Aug 2009 14:54:53 -0400</pubDate>
								</item><item>
								<title>Computed Tomographic Colonography: Current Perspectives and Future Directions</title>
								<itunes:subtitle>Dr. Don Rockey discusses current perspectives and future directions of computed tomographic (CT) colonography</itunes:subtitle>
								<itunes:summary><![CDATA[ Computed tomographic (CT) colonography is the subject of an article in the “Mini-Reviews and Perspectives” section of the July 2009 issue of Gastroenterology. Dr. Kuemmerle speaks to the author, Dr. Don Rockey of University of Texas Southwestern Medical Center, about current perspectives and future directions of this fast-rising colon cancer screening method. ]]></itunes:summary>
								<description>Dr. Don Rockey discusses current perspectives and future directions of computed tomographic (CT) colonography</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-08-31_20090731_20090701_gastro_podcast_july_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-08-31_20090731_20090701_gastro_podcast_july_2009.mp3" length="8425821" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-08-31_20090731_20090701_gastro_podcast_july_2009.mp3</guid>
								<itunes:duration>11:41</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 31 Aug 2009 14:54:53 -0400</pubDate>
								</item><item>
								<title>Reducing Extracellular pH Sensitizes the Acinar Cell to Secretagogue-Induced Pancreatitis Responses in Rats</title>
								<itunes:subtitle>A new study by Dr. Fred Gorelick examines whether or not exposure to an acid load might sensitize the acinar cell to secretagogue-induced pancreatitis.</itunes:subtitle>
								<itunes:summary><![CDATA[ A new study examines whether or not exposure to an acid load might sensitize the acinar cell to secretagogue-induced pancreatitis. Dr. Kuemmerle speaks with Dr. Fred Gorelick of Yale University School of Medicine about this study in the September issue of Gastroenterology. ]]></itunes:summary>
								<description>A new study by Dr. Fred Gorelick examines whether or not exposure to an acid load might sensitize the acinar cell to secretagogue-induced pancreatitis.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-08-31_gastroenterology_podcast_september_2009_2.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-08-31_gastroenterology_podcast_september_2009_2.mp3" length="11647800" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-08-31_gastroenterology_podcast_september_2009_2.mp3</guid>
								<itunes:duration>16:10</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 31 Aug 2009 14:54:52 -0400</pubDate>
								</item><item>
								<title>Fecal Incontinence in US Adults: Epidemiology and Risk Factors</title>
								<itunes:subtitle>A study in the August 2009 issue of Gastroenterology set out to estimate the prevalence of different types and frequencies of fecal incontinence, describe demographic f</itunes:subtitle>
								<itunes:summary><![CDATA[ Dr. William Whitehead of the University of North Carolina at Chapel Hill discusses his study in the August 2009 issue of Gastroenterology, which set out to estimate the prevalence of different types and frequencies of fecal incontinence, describe demographic factors, and identify risk factors ]]></itunes:summary>
								<description>A study in the August 2009 issue of Gastroenterology set out to estimate the prevalence of different types and frequencies of fecal incontinence, describe demographic f</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-07-31_gastroenterology_podcast_august_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-07-31_gastroenterology_podcast_august_2009.mp3" length="10337060" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-07-31_gastroenterology_podcast_august_2009.mp3</guid>
								<itunes:duration>14:17</itunes:duration>
									<author>gastropodcast@gastro.org (AGA)</author>
									<itunes:author>gastropodcast@gastro.org</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Fri, 31 Jul 2009 14:44:20 -0400</pubDate>
								</item><item>
								<title>A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus</title>
								<itunes:subtitle>Dr. Kuemmerle speaks with Dr. John Inadomi, author of a study in the June issue of Gastroenterology that compares the cost utility of ablation with that of endoscopic surveillance strategies.</itunes:subtitle>
								<itunes:summary><![CDATA[ Dr. Kuemmerle speaks with Dr. John Inadomi, author of a study in the June issue of Gastroenterology that compares the cost utility of ablation with that of endoscopic surveillance strategies.  ]]></itunes:summary>
								<description>Dr. Kuemmerle speaks with Dr. John Inadomi, author of a study in the June issue of Gastroenterology that compares the cost utility of ablation with that of endoscopic surveillance strategies.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-05-27_gastroenterology_podcast_june_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-05-27_gastroenterology_podcast_june_2009.mp3" length="12481561" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-05-27_gastroenterology_podcast_june_2009.mp3</guid>
								<itunes:duration>17:19</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>gastropodcast@gastro.org</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Wed, 27 May 2009 17:45:40 -0400</pubDate>
								</item><item>
								<title>Tests of Gastric Neuromuscular Function</title>
								<itunes:subtitle>Dr. Kuemmerle speaks with Dr. Henry Parkman and Dr. Michael Jones, authors of a fascinating review article in the May Gastroenterology that describes tests of gastric function , provides the methodologies behind them and details the physiology that they a</itunes:subtitle>
								<itunes:summary><![CDATA[ Dr. Kuemmerle speaks with Dr. Henry Parkman and Dr. Michael Jones, authors of a fascinating review article in the May Gastroenterology that describes tests of gastric function , provides the methodologies behind them and details the physiology that they assess, as well as their clinical utility. The first of two Gastroenterology podcasts for May 2009. ]]></itunes:summary>
								<description>Dr. Kuemmerle speaks with Dr. Henry Parkman and Dr. Michael Jones, authors of a fascinating review article in the May Gastroenterology that describes tests of gastric function , provides the methodologies behind them and details the physiology that they a</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-04-27_gastro_podcast_may_2009_no1.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-04-27_gastro_podcast_may_2009_no1.mp3" length="12936654" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-04-27_gastro_podcast_may_2009_no1.mp3</guid>
								<itunes:duration>17:57</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 27 Apr 2009 11:46:00 -0400</pubDate>
								</item><item>
								<title>Heritability of Nonalcoholic Fatty Liver Disease</title>
								<itunes:subtitle>Dr. Kuemmerle interviews Dr. Jeffrey Schwimmer, lead author of an article in the May Gastroenterology that studies the role of familial factors in identifying individuals at high risk for NAFLD. The second of two Gastroenterology podcasts for May 2009.</itunes:subtitle>
								<itunes:summary><![CDATA[ Dr. Kuemmerle interviews Dr. Jeffrey Schwimmer, lead author of an article in the May Gastroenterology that studies the role of familial factors in identifying individuals at high risk for NAFLD. The second of two Gastroenterology podcasts for May 2009. ]]></itunes:summary>
								<description>Dr. Kuemmerle interviews Dr. Jeffrey Schwimmer, lead author of an article in the May Gastroenterology that studies the role of familial factors in identifying individuals at high risk for NAFLD. The second of two Gastroenterology podcasts for May 2009.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-04-27_gastro_podcast_may_2009_no2.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-04-27_gastro_podcast_may_2009_no2.mp3" length="12476405" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-04-27_gastro_podcast_may_2009_no2.mp3</guid>
								<itunes:duration>17:19</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 27 Apr 2009 11:46:00 -0400</pubDate>
								</item><item>
								<title>Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection</title>
								<itunes:subtitle>The authors of a study in the April issue of Gastroenterology have developed a clinical prediction rule for recurrent Clostridium difficile infection (CDI) that identifies high-risk patients likely to benefit from preventive measures against recurrence.</itunes:subtitle>
								<itunes:summary><![CDATA[ The authors of a study in the April issue of Gastroenterology have developed a clinical prediction rule for recurrent Clostridium difficile infection (CDI) that identifies high-risk patients likely to benefit from preventive measures against recurrence.  Dr. Kuemmerle speaks with the senior author of the paper, Dr.  Ciarán Kelly, as well as Dr. Christina Surawicz, author of a related editorial about these findings.  ]]></itunes:summary>
								<description>The authors of a study in the April issue of Gastroenterology have developed a clinical prediction rule for recurrent Clostridium difficile infection (CDI) that identifies high-risk patients likely to benefit from preventive measures against recurrence.</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-03-30_gastro_podcast_april_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-03-30_gastro_podcast_april_2009.mp3" length="10428490" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-03-30_gastro_podcast_april_2009.mp3</guid>
								<itunes:duration>14:28</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:keywords>gastroenterology, gastroenterology journal, AGA, AGA Institute</itunes:keywords><itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 30 Mar 2009 14:15:38 -0400</pubDate>
								</item><item>
								<title>A Combination of Therapies Improves Virologic Responses In Patients With Chronic Hepatitis C (Genotype 4)</title>
								<itunes:subtitle>Dr. Kuemmerle, Dr. Emmet Keeffe and Dr. Michael W. Fried discuss study results that show the combination of nitazoxanide, peginterferon alfa-2a, and ribavirin improved percentages of patients with rapid virologic response (RVR) and sustained ...</itunes:subtitle>
								<itunes:summary><![CDATA[ Dr. Kuemmerle, Dr. Emmet Keeffe and Dr. Michael W. Fried discuss study results that show the combination of nitazoxanide, peginterferon alfa-2a, and ribavirin improved percentages of patients with rapid virologic response (RVR) and sustained virologic response (SVR). ]]></itunes:summary>
								<description>Dr. Kuemmerle, Dr. Emmet Keeffe and Dr. Michael W. Fried discuss study results that show the combination of nitazoxanide, peginterferon alfa-2a, and ribavirin improved percentages of patients with rapid virologic response (RVR) and sustained ...</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-03-04_gastro_podcast_march_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-03-04_gastro_podcast_march_2009.mp3" length="14522577" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-03-04_gastro_podcast_march_2009.mp3</guid>
								<itunes:duration>20:09</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>AGA Institute</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Wed, 04 Mar 2009 11:54:44 -0500</pubDate>
								</item><item>
								<title>Infliximab Prevents Crohn&amp;apos;s Disease Recurrence After Ileal Resection</title>
								<itunes:subtitle>February 2009</itunes:subtitle>
								<itunes:summary><![CDATA[ February 2009 ]]></itunes:summary>
								<description>February 2009</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-02-27_20090129_gastro_podcast_february_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2009-02-27_20090129_gastro_podcast_february_2009.mp3" length="8539635" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2009-02-27_20090129_gastro_podcast_february_2009.mp3</guid>
								<itunes:duration>11:46</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>gastropodcast@gastro.org</itunes:author>
									<itunes:explicit>no</itunes:explicit>
									<pubDate>Fri, 27 Feb 2009 14:23:30 -0500</pubDate>
								</item><item>
								<title>Presentation and Long Term Follow-Up of Refractory Celiac Disease - Comparison of Type I With Type II</title>
								<itunes:subtitle>January 2009</itunes:subtitle>
								<itunes:summary><![CDATA[ January 2009 ]]></itunes:summary>
								<description>January 2009</description>
								<link>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2008-12-29_gastro_podcast_january_2009.mp3</link>
								<enclosure url="http://digitalstash.net/podcasts/AGA/GASTRO//media/2008-12-29_gastro_podcast_january_2009.mp3" length="9998400" type="audio/mpeg"/>
								<guid>http://digitalstash.net/podcasts/AGA/GASTRO//?p=episode&amp;name=2008-12-29_gastro_podcast_january_2009.mp3</guid>
								<itunes:duration>13:53</itunes:duration>
									<author>gastropodcast@gastro.org (AGA Institute)</author>
									<itunes:author>gastropodcast@gastro.org</itunes:author>
									<itunes:keywords>Gastroenterology Journal</itunes:keywords><itunes:explicit>no</itunes:explicit>
									<pubDate>Mon, 29 Dec 2008 11:29:32 -0500</pubDate>
								</item></channel></rss>